E-LIB Suche - Ergebnisse für: Paubel, P

1

HTA143 Drug Market Access Delays in France: What Role May C..:

Cartolano, P. ; Tano, M. ; Siorat, V....
Value in Health. 26 (2023) 12 - p. S346 , 2023

Link: https://doi.org/10.1016/..

2

EE580 New Anti-CGRP in France: Estimated Financial Impact o..:

Cartolano, P. ; Tano, M. ; Siorat, V....
Value in Health. 26 (2023) 12 - p. S164-S165 , 2023

Link: https://doi.org/10.1016/..

3

EE124 Analysis of the Use of the Haute Autorité De Santé (H..:

Moutier, H. ; Paubel, P. ; Fusier, I..
Value in Health. 26 (2023) 12 - p. S74 , 2023

Link: https://doi.org/10.1016/..

4

HPR194 New Framework for Early Access to Drugs in France: F..:

Denoual, C. ; Siorat, V. ; Fusier, I...
Value in Health. 26 (2023) 12 - p. S287 , 2023

Link: https://doi.org/10.1016/..

5

OP8 A New Complement Inhibitor: Impact of Ravulizumab on Ec..:

Romero, C. ; Fusier, I. ; Siorat, V...
Value in Health. 26 (2023) 12 - p. S443 , 2023

Link: https://doi.org/10.1016/..

6

OP19 Monoclonal Antibodies in Oncology: A Comparative Analy..:

Moracchini, M. ; Tano, M. ; Siorat, V....
Value in Health. 26 (2023) 12 - p. S445 , 2023

Link: https://doi.org/10.1016/..

7

OP25 Developments in Anticancer Drugs Preparation Activity ..:

Moracchini, M. ; Tano, M. ; Siorat, V....
Value in Health. 26 (2023) 12 - p. S446 , 2023

Link: https://doi.org/10.1016/..

8

Prices of Orphan Drugs in Four Western European Countries B..:

Dane, Aniek ; Klein Gebbink, Anne-Sophie ; Brugma, Jan-Dietert...
Applied Health Economics and Health Policy. 21 (2023) 6 - p. 905-914 , 2023

Link: https://doi.org/10.1007/..

9

Management of perioperative iron deficiency anemia as part ..:

Lasocki, Sigismond ; Delahaye, D. ; Fuks, D....
Transfusion. 63 (2023) 9 - p. 1692-1700 , 2023

Link: https://doi.org/10.1111/..

10

HPR153 Market Access Strategies for Advanced Therapy Drugs:..:

Claver Sicilia, C. ; Paubel, P. ; Fusier, I..
Value in Health. 26 (2023) 12 - p. S280 , 2023

Link: https://doi.org/10.1016/..

11

HPR28 Assessment of the French National Experimentation for..:

Tano, M ; Degrassat Theas, A ; Ribault, M.
Value in Health. 25 (2022) 7 - p. S471-S472 , 2022

Link: https://doi.org/10.1016/..

12

HPR154 Appropriate Use of Anti-PD(L)1 in Paris Public Hospi..:

Grangé, L ; Siorat, V ; Fusier, I..
Value in Health. 25 (2022) 12 - p. S260 , 2022

Link: https://doi.org/10.1016/..

13

HPR26 Anti-PD(L)1: Does the Cost of Treatment Have an Impac..:

Grangé, L ; Siorat, V ; Fusier, I..
Value in Health. 25 (2022) 12 - p. S237 , 2022

Link: https://doi.org/10.1016/..

14

HPR14 Identifying the Key Drivers of Biosimilar Uptake in P..:

Boudjenah, Y ; Tano, M ; Siorat, V...
Value in Health. 25 (2022) 12 - p. S234 , 2022

Link: https://doi.org/10.1016/..

15

HPR208 Analysis of Substitution Procurement Agreements and ..:

Guichard, L ; Delion, M ; Monnier, M...
Value in Health. 25 (2022) 12 - p. S271 , 2022

Link: https://doi.org/10.1016/..